Gauri Sabnis

2.6k total citations
60 papers, 2.0k citations indexed

About

Gauri Sabnis is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Gauri Sabnis has authored 60 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Genetics, 33 papers in Molecular Biology and 27 papers in Oncology. Recurrent topics in Gauri Sabnis's work include Estrogen and related hormone effects (43 papers), HER2/EGFR in Cancer Research (16 papers) and Histone Deacetylase Inhibitors Research (12 papers). Gauri Sabnis is often cited by papers focused on Estrogen and related hormone effects (43 papers), HER2/EGFR in Cancer Research (16 papers) and Histone Deacetylase Inhibitors Research (12 papers). Gauri Sabnis collaborates with scholars based in United States, United Kingdom and Brazil. Gauri Sabnis's co-authors include Angela Brodie, Luciana F. Macedo, Angela Brodie, Saranya Chumsri, Danijela Jelovac, Olga Goloubeva, Olga Goloubeva, Preeti Shah, Timothy R. Howes and Ting Bao and has published in prestigious journals such as Cancer, Cancer Research and Scientific Reports.

In The Last Decade

Gauri Sabnis

58 papers receiving 1.9k citations

Peers

Gauri Sabnis

GENET

ONCOL

PRM

Brian J. Long United States

Eric A. Ariazi United States

Angela Brodie United States

Luciana F. Macedo United States

Alan E. Wakeling United Kingdom

Masami Kusaka Japan

Martin R. Schneider Germany

Jeanne M. Danes United States

Jean Bowler United Kingdom

Mirra Chung United States

Brian J. Long United States

Gauri Sabnis

911 ×0.9

1.2k ×1.2

GENET

779 ×0.9

ONCOL

370 ×0.9

PRM

429 ×1.0

Citations per year, relative to Gauri Sabnis Gauri Sabnis (= 1×) peers Brian J. Long

Countries citing papers authored by Gauri Sabnis

Since Specialization

Citations

This map shows the geographic impact of Gauri Sabnis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gauri Sabnis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gauri Sabnis more than expected).

Fields of papers citing papers by Gauri Sabnis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gauri Sabnis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gauri Sabnis. The network helps show where Gauri Sabnis may publish in the future.

Co-authorship network of co-authors of Gauri Sabnis

This figure shows the co-authorship network connecting the top 25 collaborators of Gauri Sabnis. A scholar is included among the top collaborators of Gauri Sabnis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gauri Sabnis. Gauri Sabnis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kazi, Armina A., et al.. (2015). Histone Deacetylase Inhibitor Entinostat Inhibits Tumor-Initiating Cells in Triple-Negative Breast Cancer Cells. Molecular Cancer Therapeutics. 14(8). 1848–1857. 79 indexed citations

Sabnis, Gauri, Bambang S. Adiwijaya, Gabriela Garcia, et al.. (2015). Seribantumab, an Anti-ERBB3 Antibody, Delays the Onset of Resistance and Restores Sensitivity to Letrozole in an Estrogen Receptor–Positive Breast Cancer Model. Molecular Cancer Therapeutics. 14(11). 2642–2652. 19 indexed citations

Goloubeva, Olga, et al.. (2015). A nude mouse model of obesity to study the mechanisms of resistance to aromatase inhibitors. Endocrine Related Cancer. 22(4). 645–656. 14 indexed citations

Shah, Preeti, Gauri Sabnis, Olga Goloubeva, et al.. (2015). Histone deacetylase inhibitor entinostat in combination with a retinoid downregulates HER2 and reduces the tumor initiating cell population in aromatase inhibitor-resistant breast cancer. Breast Cancer Research and Treatment. 152(3). 499–508. 10 indexed citations

Kazi, Armina A., Rabia A. Gilani, Saranya Chumsri, et al.. (2014). Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancer. Breast Cancer Research. 16(1). R15–R15. 33 indexed citations

Sabnis, Gauri, Olga Goloubeva, Armina A. Kazi, Preeti Shah, & Angela Brodie. (2013). HDAC Inhibitor Entinostat Restores Responsiveness of Letrozole-Resistant MCF-7Ca Xenografts to Aromatase Inhibitors through Modulation of Her-2. Molecular Cancer Therapeutics. 12(12). 2804–2816. 53 indexed citations

Sabnis, Gauri, et al.. (2013). Effect of selumetinib on the growth of anastrozole-resistant tumors. Breast Cancer Research and Treatment. 138(3). 699–708. 11 indexed citations

Gilani, Rabia A., Armina A. Kazi, Preeti Shah, et al.. (2012). The importance of HER2 signaling in the tumor-initiating cell population in aromatase inhibitor-resistant breast cancer. Breast Cancer Research and Treatment. 135(3). 681–692. 31 indexed citations

Sabnis, Gauri, Olga Goloubeva, Saranya Chumsri, et al.. (2011). Functional Activation of the Estrogen Receptor-α and Aromatase by the HDAC Inhibitor Entinostat Sensitizes ER-Negative Tumors to Letrozole. Cancer Research. 71(5). 1893–1903. 126 indexed citations

10.

Sabnis, Gauri, et al.. (2011). Synthesis and in vitro Characterization of Semitelechelic Poly[N‐(2‐hydroxypropyl)methacrylamide]–Trastuzumab Conjugates Targeted to Breast Cancer. Macromolecular Bioscience. 12(1). 55–60. 4 indexed citations

11.

Chumsri, Saranya, Gauri Sabnis, Timothy R. Howes, & Angela Brodie. (2011). Aromatase inhibitors and xenograft studies. Steroids. 76(8). 730–735. 13 indexed citations

12.

Brodie, Angela, et al.. (2011). Extending aromatase inhibitor sensitivity in hormone resistant breast cancer. Hormone Molecular Biology and Clinical Investigation. 5(2). 97–103. 3 indexed citations

13.

Brodie, Angela & Gauri Sabnis. (2011). Adaptive Changes Result in Activation of Alternate Signaling Pathways and Acquisition of Resistance to Aromatase Inhibitors. Clinical Cancer Research. 17(13). 4208–4213. 24 indexed citations

14.

Sabnis, Gauri, Olga Goloubeva, Rabia A. Gilani, Luciana F. Macedo, & Angela Brodie. (2010). Sensitivity to the Aromatase Inhibitor Letrozole Is Prolonged After a “Break” in Treatment. Molecular Cancer Therapeutics. 9(1). 46–56. 21 indexed citations

15.

Sabnis, Gauri & Angela Brodie. (2010). Understanding Resistance to Endocrine Agents: Molecular Mechanisms and Potential for Intervention. Clinical Breast Cancer. 10(1). E6–E15. 21 indexed citations

16.

Tilghman, Syreeta L., Gauri Sabnis, & Angela Brodie. (2010). Upregulation of AIB1, aromatase and ERα provides long-term estrogen-deprived human breast cancer cells with a mechanistic growth advantage for survival. Hormone Molecular Biology and Clinical Investigation. 3(1). 357–366. 11 indexed citations

17.

Schayowitz, Adam, Gauri Sabnis, Olga Goloubeva, Vincent C.O. Njar, & A. Brodie. (2010). Prolonging hormone sensitivity in prostate cancer xenografts through dual inhibition of AR and mTOR. British Journal of Cancer. 103(7). 1001–1007. 26 indexed citations

18.

Brodie, A., Gauri Sabnis, & Luciana F. Macedo. (2007). Xenograft models for aromatase inhibitor studies. The Journal of Steroid Biochemistry and Molecular Biology. 106(1-5). 119–124. 19 indexed citations

19.

Sabnis, Gauri, Danijela Jelovac, Brian J. Long, et al.. (2006). Mammalian target of rapamycin (mTOR) as a target in human breast cancer cells that have acquired resistance to aromatase inhibitor letrozole. Cancer Research. 66. 547–547. 4 indexed citations

20.

Brodie, A., Gauri Sabnis, & Danijela Jelovac. (2006). Aromatase and breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 102(1-5). 97–102. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact